We found that decreased FGFR2 expression was associated with short patient OS in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), EAC, HNSC, KIRC, LUAD, and LUSC, while increased FGFR2 expression was associated with short patient OS in KIRP (Figure 8A). This evidence concerns the gene FGFR2 and endocervical adenocarcinoma.